nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—HCN1—brain—conduct disorder	0.0533	0.167	CbGeAlD
Dronedarone—HCN4—brain—conduct disorder	0.0404	0.126	CbGeAlD
Dronedarone—HCN3—brain—conduct disorder	0.0327	0.102	CbGeAlD
Dronedarone—HCN2—brain—conduct disorder	0.0306	0.0957	CbGeAlD
Dronedarone—CACNB4—brain—conduct disorder	0.0202	0.063	CbGeAlD
Dronedarone—KCNK2—brain—conduct disorder	0.0179	0.0558	CbGeAlD
Dronedarone—CACNB1—brain—conduct disorder	0.0161	0.0503	CbGeAlD
Dronedarone—CACNB3—brain—conduct disorder	0.0154	0.0482	CbGeAlD
Dronedarone—CACNB2—brain—conduct disorder	0.0104	0.0324	CbGeAlD
Dronedarone—SCN1A—brain—conduct disorder	0.0101	0.0315	CbGeAlD
Dronedarone—ADRA1B—brain—conduct disorder	0.00919	0.0287	CbGeAlD
Dronedarone—CACNA1D—brain—conduct disorder	0.00906	0.0283	CbGeAlD
Dronedarone—ADRA1D—brain—conduct disorder	0.00899	0.0281	CbGeAlD
Dronedarone—CACNA1C—brain—conduct disorder	0.00837	0.0261	CbGeAlD
Dronedarone—ADRB1—brain—conduct disorder	0.00653	0.0204	CbGeAlD
Dronedarone—ALB—brain—conduct disorder	0.00649	0.0203	CbGeAlD
Dronedarone—ADRA2B—Monoamine GPCRs—HTR2A—conduct disorder	0.00539	0.00792	CbGpPWpGaD
Dronedarone—ADRA2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00526	0.00774	CbGpPWpGaD
Dronedarone—ADRA1A—brain—conduct disorder	0.00516	0.0161	CbGeAlD
Dronedarone—ADRB1—G alpha (s) signalling events—CGA—conduct disorder	0.00516	0.00759	CbGpPWpGaD
Dronedarone—ADRA2C—Monoamine GPCRs—HTR2A—conduct disorder	0.00503	0.0074	CbGpPWpGaD
Dronedarone—ADRA1D—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00501	0.00737	CbGpPWpGaD
Dronedarone—KCNH2—brain—conduct disorder	0.00499	0.0156	CbGeAlD
Dronedarone—ADRA1B—Monoamine GPCRs—HTR2A—conduct disorder	0.00495	0.00728	CbGpPWpGaD
Dronedarone—ADRA2C—brain—conduct disorder	0.00492	0.0154	CbGeAlD
Dronedarone—CACNB3—Transmission across Chemical Synapses—COMT—conduct disorder	0.00486	0.00715	CbGpPWpGaD
Dronedarone—CACNB3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00483	0.0071	CbGpPWpGaD
Dronedarone—CACNB1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00473	0.00696	CbGpPWpGaD
Dronedarone—CACNB2—Neuronal System—GABRA2—conduct disorder	0.00473	0.00696	CbGpPWpGaD
Dronedarone—CACNB1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.0047	0.00691	CbGpPWpGaD
Dronedarone—CACNB4—Neuronal System—COMT—conduct disorder	0.00466	0.00686	CbGpPWpGaD
Dronedarone—CACNB4—Neuronal System—MAOA—conduct disorder	0.00463	0.00681	CbGpPWpGaD
Dronedarone—ADRB1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00457	0.00672	CbGpPWpGaD
Dronedarone—ADRA2B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00453	0.00666	CbGpPWpGaD
Dronedarone—ADRA1A—Monoamine GPCRs—HTR2A—conduct disorder	0.0044	0.00647	CbGpPWpGaD
Dronedarone—KCNK2—Neuronal System—COMT—conduct disorder	0.00438	0.00645	CbGpPWpGaD
Dronedarone—KCNK2—Neuronal System—MAOA—conduct disorder	0.00435	0.0064	CbGpPWpGaD
Dronedarone—ADRA2C—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00423	0.00622	CbGpPWpGaD
Dronedarone—ADRA1B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00416	0.00612	CbGpPWpGaD
Dronedarone—ADRA2A—Monoamine GPCRs—HTR2A—conduct disorder	0.00409	0.00601	CbGpPWpGaD
Dronedarone—ADRA1D—GPCRs, Other—DRD4—conduct disorder	0.00406	0.00597	CbGpPWpGaD
Dronedarone—ADRA2A—brain—conduct disorder	0.00393	0.0123	CbGeAlD
Dronedarone—KCNH2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0039	0.00573	CbGpPWpGaD
Dronedarone—KCNH2—Neuronal System—GABRA2—conduct disorder	0.00386	0.00567	CbGpPWpGaD
Dronedarone—CACNB3—Neuronal System—COMT—conduct disorder	0.00373	0.00548	CbGpPWpGaD
Dronedarone—CACNB3—Neuronal System—MAOA—conduct disorder	0.0037	0.00544	CbGpPWpGaD
Dronedarone—ADRA1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0037	0.00544	CbGpPWpGaD
Dronedarone—CACNB1—Neuronal System—COMT—conduct disorder	0.00363	0.00533	CbGpPWpGaD
Dronedarone—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.00362	0.00533	CbGpPWpGaD
Dronedarone—CACNB1—Neuronal System—MAOA—conduct disorder	0.0036	0.00529	CbGpPWpGaD
Dronedarone—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00349	0.00514	CbGpPWpGaD
Dronedarone—ADRA2A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00343	0.00505	CbGpPWpGaD
Dronedarone—CYP2D6—brain—conduct disorder	0.00304	0.0095	CbGeAlD
Dronedarone—CACNB2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00297	0.00437	CbGpPWpGaD
Dronedarone—CACNB2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00295	0.00434	CbGpPWpGaD
Dronedarone—KCNH2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00293	0.00431	CbGpPWpGaD
Dronedarone—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0027	0.00397	CbGpPWpGaD
Dronedarone—ADRA1D—GPCRs, Other—HTR2A—conduct disorder	0.00265	0.0039	CbGpPWpGaD
Dronedarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00246	0.00362	CbGpPWpGaD
Dronedarone—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00244	0.00358	CbGpPWpGaD
Dronedarone—KCNH2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00239	0.00352	CbGpPWpGaD
Dronedarone—CACNB2—Neuronal System—COMT—conduct disorder	0.00228	0.00335	CbGpPWpGaD
Dronedarone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00228	0.00335	CbGpPWpGaD
Dronedarone—CACNB2—Neuronal System—MAOA—conduct disorder	0.00226	0.00332	CbGpPWpGaD
Dronedarone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00224	0.00329	CbGpPWpGaD
Dronedarone—ABCB1—brain—conduct disorder	0.00219	0.00683	CbGeAlD
Dronedarone—CACNB3—Metabolism—CGA—conduct disorder	0.00208	0.00306	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR ligand binding—CGA—conduct disorder	0.00206	0.00302	CbGpPWpGaD
Dronedarone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00199	0.00293	CbGpPWpGaD
Dronedarone—ADRB1—GPCR ligand binding—CGA—conduct disorder	0.00187	0.00275	CbGpPWpGaD
Dronedarone—KCNH2—Neuronal System—COMT—conduct disorder	0.00186	0.00273	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR ligand binding—CGA—conduct disorder	0.00186	0.00273	CbGpPWpGaD
Dronedarone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00185	0.00272	CbGpPWpGaD
Dronedarone—KCNH2—Neuronal System—MAOA—conduct disorder	0.00184	0.00271	CbGpPWpGaD
Dronedarone—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00176	0.00259	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR ligand binding—CGA—conduct disorder	0.00173	0.00255	CbGpPWpGaD
Dronedarone—ADRA2B—G alpha (i) signalling events—DRD4—conduct disorder	0.00172	0.00252	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR ligand binding—CGA—conduct disorder	0.00171	0.00251	CbGpPWpGaD
Dronedarone—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00164	0.00241	CbGpPWpGaD
Dronedarone—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00161	0.00236	CbGpPWpGaD
Dronedarone—ADRA2C—G alpha (i) signalling events—DRD4—conduct disorder	0.0016	0.00236	CbGpPWpGaD
Dronedarone—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00159	0.00234	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.00152	0.00223	CbGpPWpGaD
Dronedarone—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00151	0.00222	CbGpPWpGaD
Dronedarone—ADRA1D—G alpha (q) signalling events—HTR2A—conduct disorder	0.00149	0.00219	CbGpPWpGaD
Dronedarone—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00149	0.00219	CbGpPWpGaD
Dronedarone—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00146	0.00215	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.00141	0.00207	CbGpPWpGaD
Dronedarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00138	0.00203	CbGpPWpGaD
Dronedarone—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00136	0.00201	CbGpPWpGaD
Dronedarone—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00133	0.00196	CbGpPWpGaD
Dronedarone—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.0013	0.00192	CbGpPWpGaD
Dronedarone—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0013	0.00191	CbGpPWpGaD
Dronedarone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00127	0.00187	CbGpPWpGaD
Dronedarone—CACNB2—Metabolism—CGA—conduct disorder	0.00127	0.00187	CbGpPWpGaD
Dronedarone—KCNH2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00127	0.00186	CbGpPWpGaD
Dronedarone—CACNB4—Developmental Biology—EP300—conduct disorder	0.00127	0.00186	CbGpPWpGaD
Dronedarone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00125	0.00185	CbGpPWpGaD
Dronedarone—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.00124	0.00182	CbGpPWpGaD
Dronedarone—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00121	0.00178	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—CGA—conduct disorder	0.0012	0.00177	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—CGA—conduct disorder	0.00116	0.00171	CbGpPWpGaD
Dronedarone—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00115	0.00169	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR ligand binding—DRD4—conduct disorder	0.00115	0.00169	CbGpPWpGaD
Dronedarone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00111	0.00164	CbGpPWpGaD
Dronedarone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00111	0.00163	CbGpPWpGaD
Dronedarone—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.0011	0.00161	CbGpPWpGaD
Dronedarone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00107	0.00158	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—CGA—conduct disorder	0.00106	0.00156	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—CGA—conduct disorder	0.00106	0.00155	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—CGA—conduct disorder	0.00105	0.00155	CbGpPWpGaD
Dronedarone—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00105	0.00154	CbGpPWpGaD
Dronedarone—ADRB1—GPCR ligand binding—DRD4—conduct disorder	0.00105	0.00154	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.00105	0.00154	CbGpPWpGaD
Dronedarone—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00104	0.00153	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.00104	0.00153	CbGpPWpGaD
Dronedarone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00104	0.00152	CbGpPWpGaD
Dronedarone—CACNB3—Developmental Biology—EP300—conduct disorder	0.00101	0.00149	CbGpPWpGaD
Dronedarone—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000986	0.00145	CbGpPWpGaD
Dronedarone—CACNB1—Developmental Biology—EP300—conduct disorder	0.000984	0.00145	CbGpPWpGaD
Dronedarone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000982	0.00144	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	0.00098	0.00144	CbGpPWpGaD
Dronedarone—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000971	0.00143	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	0.000971	0.00143	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.000964	0.00142	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—CGA—conduct disorder	0.000961	0.00141	CbGpPWpGaD
Dronedarone—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000955	0.00141	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.000955	0.00141	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—CGA—conduct disorder	0.000952	0.0014	CbGpPWpGaD
Dronedarone—CACNB3—Metabolism—COMT—conduct disorder	0.000939	0.00138	CbGpPWpGaD
Dronedarone—CACNB3—Metabolism—MAOA—conduct disorder	0.000932	0.00137	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000905	0.00133	CbGpPWpGaD
Dronedarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000899	0.00132	CbGpPWpGaD
Dronedarone—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00089	0.00131	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—CGA—conduct disorder	0.00089	0.00131	CbGpPWpGaD
Dronedarone—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000878	0.00129	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.000876	0.00129	CbGpPWpGaD
Dronedarone—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000872	0.00128	CbGpPWpGaD
Dronedarone—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000866	0.00127	CbGpPWpGaD
Dronedarone—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00086	0.00126	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.000856	0.00126	CbGpPWpGaD
Dronedarone—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000849	0.00125	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.000849	0.00125	CbGpPWpGaD
Dronedarone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000832	0.00122	CbGpPWpGaD
Dronedarone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000819	0.0012	CbGpPWpGaD
Dronedarone—ALB—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000807	0.00119	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	0.000796	0.00117	CbGpPWpGaD
Dronedarone—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000789	0.00116	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	0.000789	0.00116	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.000778	0.00114	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	0.000751	0.0011	CbGpPWpGaD
Dronedarone—SCN1A—Developmental Biology—EP300—conduct disorder	0.000739	0.00109	CbGpPWpGaD
Dronedarone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000727	0.00107	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—CGA—conduct disorder	0.000723	0.00106	CbGpPWpGaD
Dronedarone—CACNA1S—Developmental Biology—EP300—conduct disorder	0.000721	0.00106	CbGpPWpGaD
Dronedarone—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000707	0.00104	CbGpPWpGaD
Dronedarone—ADRB1—GPCR ligand binding—HTR2A—conduct disorder	0.000684	0.00101	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	0.000678	0.000997	CbGpPWpGaD
Dronedarone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000676	0.000994	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	0.000651	0.000957	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	0.000633	0.000931	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—CGA—conduct disorder	0.000628	0.000924	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	0.000623	0.000917	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CGA—conduct disorder	0.000623	0.000916	CbGpPWpGaD
Dronedarone—CACNB2—Developmental Biology—EP300—conduct disorder	0.000618	0.000909	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—DRD4—conduct disorder	0.000593	0.000872	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	0.000591	0.000869	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	0.000587	0.000864	CbGpPWpGaD
Dronedarone—CACNA1D—Developmental Biology—EP300—conduct disorder	0.000585	0.000861	CbGpPWpGaD
Dronedarone—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000574	0.000844	CbGpPWpGaD
Dronedarone—CACNB2—Metabolism—COMT—conduct disorder	0.000573	0.000843	CbGpPWpGaD
Dronedarone—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00057	0.000838	CbGpPWpGaD
Dronedarone—CACNB2—Metabolism—MAOA—conduct disorder	0.000569	0.000837	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CGA—conduct disorder	0.000568	0.000835	CbGpPWpGaD
Dronedarone—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000566	0.000833	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CGA—conduct disorder	0.000563	0.000827	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.000554	0.000814	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	0.000549	0.000807	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—COMT—conduct disorder	0.000543	0.000798	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	0.00054	0.000794	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—MAOA—conduct disorder	0.000539	0.000793	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—DRD4—conduct disorder	0.000538	0.000792	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	0.000533	0.000784	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CGA—conduct disorder	0.000526	0.000773	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CGA—conduct disorder	0.000517	0.000761	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	0.000514	0.000757	CbGpPWpGaD
Dronedarone—CACNA1C—Developmental Biology—EP300—conduct disorder	0.000514	0.000756	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—CGA—conduct disorder	0.00051	0.000751	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—WASF1—conduct disorder	0.000499	0.000734	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	0.000498	0.000733	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	0.00049	0.000721	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	0.00048	0.000705	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—COMT—conduct disorder	0.000477	0.000702	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—MAOA—conduct disorder	0.000474	0.000697	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CGA—conduct disorder	0.000459	0.000676	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—WASF1—conduct disorder	0.000455	0.000669	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—WASF1—conduct disorder	0.000451	0.000663	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	0.000446	0.000655	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	0.000436	0.00064	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CGA—conduct disorder	0.000427	0.000628	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	0.000424	0.000624	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—WASF1—conduct disorder	0.000421	0.000619	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—WASF1—conduct disorder	0.000414	0.00061	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	0.000405	0.000595	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CGA—conduct disorder	0.000403	0.000592	CbGpPWpGaD
Dronedarone—CACNB3—Metabolism—EP300—conduct disorder	0.000402	0.000592	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—HTR2A—conduct disorder	0.000387	0.000569	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	0.000385	0.000567	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	0.000383	0.000564	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—WASF1—conduct disorder	0.000368	0.000541	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000367	0.00054	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	0.000358	0.000526	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CGA—conduct disorder	0.000353	0.000519	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	0.000352	0.000518	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—HTR2A—conduct disorder	0.000351	0.000516	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—DRD4—conduct disorder	0.000349	0.000513	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	0.000348	0.000512	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—WASF1—conduct disorder	0.000342	0.000503	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CGA—conduct disorder	0.000333	0.000489	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	0.000325	0.000478	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—EP300—conduct disorder	0.000321	0.000472	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	0.00032	0.00047	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—DRD4—conduct disorder	0.000318	0.000468	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—DRD4—conduct disorder	0.000315	0.000463	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	0.000313	0.00046	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—EP300—conduct disorder	0.0003	0.000441	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—DRD4—conduct disorder	0.000294	0.000433	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	0.000291	0.000428	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—DRD4—conduct disorder	0.00029	0.000426	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	0.000284	0.000418	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—COMT—conduct disorder	0.000284	0.000417	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—MAOA—conduct disorder	0.000282	0.000414	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	0.000264	0.000388	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—DRD4—conduct disorder	0.000257	0.000378	CbGpPWpGaD
Dronedarone—CACNB2—Metabolism—EP300—conduct disorder	0.000246	0.000362	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—EP300—conduct disorder	0.000244	0.000358	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—DRD4—conduct disorder	0.000239	0.000352	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—EP300—conduct disorder	0.000233	0.000342	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—COMT—conduct disorder	0.00023	0.000339	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—MAOA—conduct disorder	0.000229	0.000336	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	0.000228	0.000335	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CGA—conduct disorder	0.000217	0.00032	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—HTR2A—conduct disorder	0.000207	0.000305	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	0.000206	0.000302	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—EP300—conduct disorder	0.000205	0.000301	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—EP300—conduct disorder	0.000192	0.000283	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	0.000192	0.000282	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	0.000189	0.000278	CbGpPWpGaD
Dronedarone—ALB—Metabolism—COMT—conduct disorder	0.000182	0.000267	CbGpPWpGaD
Dronedarone—ALB—Metabolism—MAOA—conduct disorder	0.000181	0.000266	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000175	0.000258	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	0.000168	0.000247	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—COMT—conduct disorder	0.000159	0.000234	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—MAOA—conduct disorder	0.000158	0.000233	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	0.000156	0.000229	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—COMT—conduct disorder	0.00015	0.000221	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—MAOA—conduct disorder	0.000149	0.000219	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—EP300—conduct disorder	0.000122	0.000179	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—EP300—conduct disorder	0.000121	0.000177	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—EP300—conduct disorder	0.00011	0.000162	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—EP300—conduct disorder	0.000109	0.00016	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—EP300—conduct disorder	0.000102	0.00015	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—EP300—conduct disorder	0.0001	0.000147	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—EP300—conduct disorder	9.88e-05	0.000145	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—COMT—conduct disorder	9.82e-05	0.000144	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—MAOA—conduct disorder	9.75e-05	0.000143	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—EP300—conduct disorder	8.89e-05	0.000131	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—EP300—conduct disorder	8.26e-05	0.000122	CbGpPWpGaD
Dronedarone—ALB—Metabolism—EP300—conduct disorder	7.8e-05	0.000115	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—EP300—conduct disorder	6.83e-05	0.0001	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—EP300—conduct disorder	6.44e-05	9.47e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—EP300—conduct disorder	4.21e-05	6.19e-05	CbGpPWpGaD
